2024-2028 NIH-Wide Strategic Plan on Research on the Health of Women
|
Other
|
AHRQ, CDC, FDA, HRSA, OASH
|
CC, CSR, NCATS, NCCIH, FIC, NCI, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINDS, NINR, NLM, OD/ AoU, OD/ DPCPSI/ OAR, OD/ DPCPSI/ OBSSR, OD/ DPCPSI/ ODS, OD/ DPCPSI/ ODSS, OD/ DPCPSI/ OEPR, OD/ DPCPSI/ ONR, OD/ DPCPSI/ SGMRO
|
2022
|
|
3D Bioprinted skin models for drug screening
|
Research Initiative
|
FDA
|
NCATS
|
|
|
A Glycopeptide from Interstitial Cystitis Patients as a Novel Anticancer Lead
|
Research Initiative
|
FDA
|
NCI
|
|
|
A Pilot Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of escalating multiple oral doses of AG-348 in subjects with stable sickle cell disease
|
Research Initiative
|
FDA
|
NHLBI
|
|
|
A Study to Evaluate the Effects of fixed dose Flavonoid Isoquercetin on thrombo-inflammatory biomarkers in subjects with stable Sickle Cell Disease
|
Research Initiative
|
FDA
|
NHLBI
|
|
|
A5418: Study of Tecovirimat For Human Monkeypox Virus (STOMP)
|
Other
|
CDC, FDA
|
NIAID
|
2022
|
|
Abuse Liability Evaluation for Research, Treatment, and Training (ALERTT)
|
Research Initiative
|
FDA
|
NIDA
|
2011
|
|
Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) Therapeutics Working Group
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, ASPR
|
NIAID
|
2020
|
|
Accelerating COVID-19 Therapeutic Interventions and Vaccines-1: Immune Modulators (ACTIV-1)
|
Research Initiative
|
FDA, ASPR
|
NCATS
|
2020
|
|
Accelerating COVID-19 Therapeutic Interventions and Vaccines-6: Outpatient Repurposed Drugs (ACTIV-6)
|
Research Initiative
|
CDC, FDA, ASPR
|
NIAID, NHLBI, NCATS
|
2021
|
|
Accelerating Medicines Partnership (AMP)
|
Other
|
FDA
|
NIA, NIDDK, NIAMS, NINDS, NIMH
|
2014
|
|
Accelerating Medicines Partnership® Schizophrenia (AMP SCZ)
|
Research Initiative
|
FDA
|
|
2020
|
|
AccessGUDID
|
Resource Development
|
FDA, GDM
|
|
2015
|
|
Adaptive Optics Imaging of Outer Retinal Diseases
|
Research Initiative
|
FDA
|
|
|
|
Adaptive Optics Retinal Imaging
|
Research Initiative
|
FDA
|
NEI
|
|
|
Adjuvant Working Group
|
Committee, Advisory Group, or Work Group
|
BARDA, FDA, ASPR
|
NCI, NIAID
|
2013
|
|
Advanced Anticonvulsant System Interagency Product Team
|
Committee, Advisory Group, or Work Group
|
FDA, OS
|
NINDS
|
2011
|
|
Advanced Viral Detection Technology IG (AVDTIG)
|
Committee, Advisory Group, or Work Group
|
CDC, FDA
|
NIAID
|
2018
|
|
Advancing American Kidney Health Initiative
|
Research Initiative
|
CDC, CMS, FDA, ASPE, ASPR, HRSA, IHS, OCR
|
NIEHS, NIDDK
|
2019
|
|
Advisory Committee on Blood and Tissue Safety and Availability (ACBTSA)
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, OS
|
NHLBI
|
2003
|
|
Advisory Committee on Heritable Disorders in Newborns and Children (ACHDNC)
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, FDA, HRSA
|
NHGRI, NHLBI, NICHD, NIDDK, NLM
|
2015
|
|
Advisory Committee on Immunization Practices (ACIP WG)
|
Committee, Advisory Group, or Work Group
|
CDC, FDA
|
NIAID
|
|
|
Advisory Committee on Maternal/Pediatric RSV Vaccines (ACIP WG)
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, OASH, HRSA, IHS, CMS
|
NIAID
|
2022
|
|
Advisory Committee on RSV Vaccines in Older Adults (ACIP WG)
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, OASH, CMS
|
|
2022
|
|
Advisory Council on Blood Stem Cell Transplantation (ACBSCT) of the U.S. Department of Health and Human Services (HHS)
|
Committee, Advisory Group, or Work Group
|
CDC, CMS, FDA, HRSA
|
NHLBI
|
2008
|
|
|